Oxervate is an eye drop for neurotrophic keratitis. Patients who experience side effects, such as blindness, may file an Oxervate lawsuit against the manufacturer, Dompé.
The Oxervate lawsuit revolves around a drug designed to treat neurotrophic keratitis, a rare eye disease. This condition affects the cornea, causing progressive deterioration and possible blindness. For many people with this debilitating disease, Oxervate has promised to restore sight.
Oxervate is an eye drop manufactured by an Italian company named Dompé Farmaceutici S.p.A. The first-line drug for neurotrophic keratitis is Oxervet, which is U.S.-exclusive. It was approved by the Food and Drug Administration (FDA) in 2018.
Some people have serious side effects from Oxervate including:
- Blindness
- Blurred vision
- Headache
- Corneal ulcers
- Corneal plaques
Due to these severe side effects, some patients and attorneys are taking legal actions against Dompé. If you have suffered an adverse effect from oxervate, soon you will file a lawsuit against the company. A legal expert can help you with your cases, guide you through the process, and protect your rights. Contact a specialized attorney to explore your case.
Sign in to leave a comment.